MEDTRONIC PLC (2M6.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:2M6 - IE00BTN1Y115 - Common Stock
82.96 EUR
-0.17 (-0.2%)
Taking everything into account, 2M6 scores 5 out of 10 in our fundamental rating. 2M6 was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 2M6 has an average financial health and profitability rating. 2M6 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 2M6 was profitable.
2M6 had a positive operating cash flow in the past year.
2M6 had positive earnings in each of the past 5 years.
In the past 5 years 2M6 always reported a positive cash flow from operatings.
1.2 Ratios
2M6 has a better Return On Assets (5.22%) than 66.15% of its industry peers.
Looking at the Return On Equity, with a value of 9.79%, 2M6 is in the better half of the industry, outperforming 64.62% of the companies in the same industry.
2M6 has a Return On Invested Capital of 6.63%. This is comparable to the rest of the industry: 2M6 outperforms 58.46% of its industry peers.
2M6 had an Average Return On Invested Capital over the past 3 years of 6.35%. This is below the industry average of 9.71%.
The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| ROIC | 6.63% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1.3 Margins
The Profit Margin of 2M6 (13.71%) is better than 80.00% of its industry peers.
2M6's Profit Margin has declined in the last couple of years.
2M6's Operating Margin of 19.42% is amongst the best of the industry. 2M6 outperforms 86.15% of its industry peers.
2M6's Operating Margin has been stable in the last couple of years.
2M6 has a better Gross Margin (65.57%) than 69.23% of its industry peers.
In the last couple of years the Gross Margin of 2M6 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.42% | ||
| PM (TTM) | 13.71% | ||
| GM | 65.57% |
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 2M6 is creating some value.
The number of shares outstanding for 2M6 has been reduced compared to 1 year ago.
Compared to 5 years ago, 2M6 has less shares outstanding
Compared to 1 year ago, 2M6 has a worse debt to assets ratio.
2.2 Solvency
2M6 has an Altman-Z score of 3.06. This indicates that 2M6 is financially healthy and has little risk of bankruptcy at the moment.
2M6's Altman-Z score of 3.06 is fine compared to the rest of the industry. 2M6 outperforms 61.54% of its industry peers.
The Debt to FCF ratio of 2M6 is 5.59, which is a neutral value as it means it would take 2M6, 5.59 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.59, 2M6 is in line with its industry, outperforming 50.77% of the companies in the same industry.
2M6 has a Debt/Equity ratio of 0.57. This is a neutral value indicating 2M6 is somewhat dependend on debt financing.
2M6's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. 2M6 is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.59 | ||
| Altman-Z | 3.06 |
ROIC/WACC1.01
WACC6.58%
2.3 Liquidity
A Current Ratio of 2.42 indicates that 2M6 has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.42, 2M6 is in the better half of the industry, outperforming 75.38% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that 2M6 should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.80, 2M6 is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.42 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.24% over the past year.
Measured over the past 5 years, 2M6 shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
Looking at the last year, 2M6 shows a small growth in Revenue. The Revenue has grown by 5.34% in the last year.
The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
3.2 Future
2M6 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.35% yearly.
2M6 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.79% yearly.
EPS Next Y3.61%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
EPS Next 5Y6.35%
Revenue Next Year7.65%
Revenue Next 2Y6.74%
Revenue Next 3Y6.23%
Revenue Next 5Y5.79%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.36 indicates a rather expensive valuation of 2M6.
86.15% of the companies in the same industry are more expensive than 2M6, based on the Price/Earnings ratio.
2M6 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.83, the valuation of 2M6 can be described as correct.
69.23% of the companies in the same industry are more expensive than 2M6, based on the Price/Forward Earnings ratio.
2M6's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.03.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.36 | ||
| Fwd PE | 15.83 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2M6 indicates a somewhat cheap valuation: 2M6 is cheaper than 63.08% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2M6 indicates a somewhat cheap valuation: 2M6 is cheaper than 75.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.08 | ||
| EV/EBITDA | 14.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2M6 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 2M6 may justify a higher PE ratio.
PEG (NY)4.81
PEG (5Y)4.71
EPS Next 2Y5.98%
EPS Next 3Y6.33%
5. Dividend
5.1 Amount
2M6 has a Yearly Dividend Yield of 2.88%.
Compared to an average industry Dividend Yield of 1.03, 2M6 pays a better dividend. On top of this 2M6 pays more dividend than 90.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, 2M6 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.88% |
5.2 History
The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
2M6 pays out 75.86% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 2M6 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP75.86%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
FRA:2M6 (12/23/2025, 7:00:00 PM)
82.96
-0.17 (-0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.76%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap106.36B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts73.33
Price Target95.97 (15.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.88% |
Yearly Dividend2.36
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)8.08%
PT rev (3m)11.68%
EPS NQ rev (1m)-0.85%
EPS NQ rev (3m)-1.13%
EPS NY rev (1m)0.29%
EPS NY rev (3m)0.51%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.36 | ||
| Fwd PE | 15.83 | ||
| P/S | 3.61 | ||
| P/FCF | 24.08 | ||
| P/OCF | 17.62 | ||
| P/B | 2.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.24 |
EPS(TTM)4.78
EY5.76%
EPS(NY)5.24
Fwd EY6.32%
FCF(TTM)3.45
FCFY4.15%
OCF(TTM)4.71
OCFY5.67%
SpS23
BVpS32.2
TBVpS-2.6
PEG (NY)4.81
PEG (5Y)4.71
Graham Number58.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| ROCE | 8.29% | ||
| ROIC | 6.63% | ||
| ROICexc | 7.39% | ||
| ROICexgc | 26.33% | ||
| OM | 19.42% | ||
| PM (TTM) | 13.71% | ||
| GM | 65.57% | ||
| FCFM | 14.98% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.59 | ||
| Debt/EBITDA | 2.83 | ||
| Cap/Depr | 63.21% | ||
| Cap/Sales | 5.49% | ||
| Interest Coverage | 8.53 | ||
| Cash Conversion | 72.83% | ||
| Profit Quality | 109.28% | ||
| Current Ratio | 2.42 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 3.06 |
F-Score8
WACC6.58%
ROIC/WACC1.01
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.61%
EPS Next 2Y5.98%
EPS Next 3Y6.33%
EPS Next 5Y6.35%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.65%
Revenue Next 2Y6.74%
Revenue Next 3Y6.23%
Revenue Next 5Y5.79%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year16.81%
EBIT Next 3Y10.65%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%
MEDTRONIC PLC / 2M6.DE FAQ
What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.
What is the valuation status of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.
How profitable is MEDTRONIC PLC (2M6.DE) stock?
MEDTRONIC PLC (2M6.DE) has a profitability rating of 6 / 10.
What are the PE and PB ratios of MEDTRONIC PLC (2M6.DE) stock?
The Price/Earnings (PE) ratio for MEDTRONIC PLC (2M6.DE) is 17.36 and the Price/Book (PB) ratio is 2.58.
How financially healthy is MEDTRONIC PLC?
The financial health rating of MEDTRONIC PLC (2M6.DE) is 6 / 10.